UK Investing $15.1M into New Synthetic Biology Center | GenomeWeb

NEW YORK (GenomeWeb News) – The UK is investing £10 million ($15.1 million) to create a new center to drive the translation of synthetic biology research into industrial applications.

The new Innovation and Knowledge Center (IKC) called SynbiCite announced today will be based at Imperial College London. Richard Kitney and Paul Freemont, professors at the university, will head the center, whose goal is to act as an industrial translation engine "that can integrate university and industry-based research in synthetic biology into industrial process and products."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.